Medical Health & Life Science Research News

Learn details of APAC's cancer diagnostics market that will be worth USD 7.10 billion till 2024

APAC Cancer Diagnostics Market By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma), By Geography (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of APAC) – Industry Trends and Forecast to 2024

- Advertising -

APAC Cancer Diagnostics Market is expected to reach USD 7.10 billion by 2024 from USD 2.70 billion in 2016, at a CAGR of 12.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Report @ databridgemarketresearch.com/reque…iagnostics-market

This report consists of below pages:

  • No of pages: 175
  • No of Figures: 30
  • No of Tables: 125

The major factors driving the growth of this market are the increasing medical tourism in Asia Pacific regions and technological development and increasing market reach by Asian countries. These factors increase the demand for cancer diagnostic products.

- Advertising -

On the other hand, stringent regulations imposed by international and local authorities and shortage of skilled and trained professionals may hinder the growth of the market.

Segmentation: APAC Cancer Diagnostics Market

The APAC cancer diagnostics market is segmented on the basis of technology, application and geography. The APAC cancer diagnostics market is segmented into 2 types- platform based and instrument based.

In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2% and is expected to continue this trend till 2024.

Browse Full Report @ databridgemarketresearch.com/repor…agnostics-market/

Cancer diagnostics platform based market is segmented into polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), next generation sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer diagnostics instrument based market is segmented into imaging and biopsy.

Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography and ultrasound.

On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Major Players: APAC Cancer Diagnostics Market

Hoffman-La Roche Ltd is going to dominate the cancer diagnostics market, by platform based following with Abbott Laboratories Inc along with QIAGEN.

Inquiry report @ databridgemarketresearch.com/inqui…iagnostics-market

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...